Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India

India's Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Pr37oD
via IFTTT